Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-215-7 | CAS number: 1313-99-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- May 29, 2009 - October 5, 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Guideline Study
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- Principles of method if other than guideline:
- Not Applicable
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- Nickel monoxide
- EC Number:
- 215-215-7
- EC Name:
- Nickel monoxide
- Cas Number:
- 1313-99-1
- Molecular formula:
- NiO
- IUPAC Name:
- oxonickel
- Details on test material:
- - Name of test material (as cited in study report): Green Nickel oxide, Code: NI26-PTL
- Physical state: dark grey powder (granules prior to grinding)
- Composition of test material, percentage of components: NiO green = 98%; CoO = 1.5%
- Expiration date of the lot/batch: Not Applicable
- Solubility: Insoluble in water
- Stability under test conditions: Test substance was expected to be stable for the duration oftesting.
- Storage condition of test material: The test substance was stored at room temperature and stored under nitrogen after initial testing.
- Other: Documentation ofthe methods ofsynthesis, fabrication, or derivation of the test substance is retained by Vale Inco Ltd. 200 Bay St. Royal Bank Plaza, Suite 1600, S. Tower, P.O. Box 70. Toronto, Ontario, CA. M5J 2K2.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Received from Ace Animals, Inc., Boyertown, PA on May 19 and July21, 2009.
- Age at study initiation: 9-10 weeks
- Weight at study initiation: males 296-335 grams and females 204-230 grams at experimental start
- Housing: suspended stainless steel caging with mesh floors. Litter paper was placed beneath the cage and was changed at least three times per week.
- Diet (e.g. ad libitum): ad libitum; Purina Rodent Chow #5012
- Water (e.g. ad libitum): tap water ad libitum
- Acclimation period: 13 or 15 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-23°C
- Humidity (%): 58-78%
- Photoperiod (hrs dark / hrs light): 12-hour light/dark cycle
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Mini Nose Only Inhalation Chamber, ADG Developments LTD
- Exposure chamber volume: 6.7 liters
- Method of holding animals in test chamber: Animals were individuallyhoused in polycarbonate holding tubes which seal to the chamber with an "0" ring during exposure.
- Source and rate of air: Filtered air was supplied by an air compressor (JUN-AIR, Model #6-15) to the dust generator. Additional compressed mixing air, supplied from a compressed air tank (Airgas), was introduced into the chamber to help uniformly distribute the test atmosphere by creating a vortex at the chamber inlet. Compressed airflow was measured with a Mass Flowmeter (Omega, Model #FMA-5613). Chamber airflow was monitored throughout the exposure period and recorded periodically.
- Method of conditioning air: The measurements inside the exposure tube were made with a Humidity-Temperature Indicator (Taylor, Model #5502) and room conditions were measured with a Temperature-Humidity Monitor (Dickson, Model #TH550). Temperature and relative humidity values were
recorded every 15 minutes for the first hour of exposure and every 30 minutes thereafter.
- System of generating particulates/aerosols: The test substance was aerosolized using a modified Wright Dust Generator driven by a variable speed motor (Dayton, Model #4Z538A) D.C. speed control with 0-100 potentiometer. The test substance was packed into the dust container (Wright, Model DF 183 or 183A) and compressed to 5,000 lbs/in^2 using a lab press (Carver, Model C). The container was then fitted with a stainless steel cutting head (Model DF 1945S or 1935S) and cutting blade (ModelDF 1915S or 1905S). Compressed air was supplied to the dust generator at 30 psi. The aerosolized dust was then fed directly into the chamber through the dust outlet assembly.
- Method of particle size determination: An eight-stage Andersen cascade impactor was used to assess the particle size distribution of the test atmosphere. Samples were withdrawn from the breathing zone of the animals at two intervals during each exposure. The filter paper collection stages were weighed before and after sampling to determine the mass collected upon each stage. The aerodynamic mass median diameter and geometric standard deviation were determined graphically using two-cycle logarithmic probit axes.
- Temperature, humidity, pressure in air chamber: 19-23°C, 58-78%, not applicable
TEST ATMOSPHERE
- Brief description of analytical method used: Gravimetric samples were withdrawn at six intervals from the breathing zone of the animals during each exposure. Samples were collected using 25 mm glass fiber filters (GF/B Whatman) in a filter holder attached by 1/4 inch tygon tubing to a vacuum pump (Reliance Electric, Model #G557X). Filterpapers were weighed before and after collection to determine the mass collected. This value was divided by the total volume of air sampled to determine tile chamber concentration. Sample airflows were measured using a Mass Flowmeter (Omega, Model #FMA-561O).
- Samples taken from breathing zone: yes
TEST ATMOSPHERE (if not tabulated)
- Particle size distribution:
- MMAD (Mass median aerodynamic diameter): 2.35 um (low dose); 3.75 um (high dose) - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- Gravimetric samples were withdrawn at six intervals from the breathing zone of the animals during each exposure. Sample airflows were measured using a Mass Flowmeter.
- Duration of exposure:
- ca. 4 h
- Concentrations:
- 0.183 mg/L (median aerodynamic diameter was estimated to be 2.35 um) and 5.08 mg/L (median aerodynamic diameter was estimated to be 3.75 um)
- No. of animals per sex per dose:
- 5 males and 5 females per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily observations; weights taken at start of study, days 7 and 14.
- Necropsy of survivors performed: yes
- Other examinations performed: daily observations included gross evaluation of skin and fur, eyes and mucous membranes, respiratory, circulatory, autonomic and central nervous systems, somatomotor activity and behavior pattern. Particular attention was directcd to observation of tremors, convulsions, salivation, diarrhea, and coma. - Statistics:
- Not Applicable
Results and discussion
- Preliminary study:
- The exposure procedures and atomization equipment used were based on the results of pre-test trial numbers 5 and 7. In each instance, the conditions ofgeneration were modified to achieve the targeted chamber concentration with a desirable particle size distribution.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.08 mg/L air (analytical)
- Exp. duration:
- 4 h
- Remarks on result:
- other: All 10 animals survived the observation period, gained weight, and appeared active and healthy.
- Mortality:
- All animals in both dose groups survived the observational 14-day period.
- Clinical signs:
- other: Immediately following exposure and throughout the 14-day observation period all animals appeared active and healthy. There were no signs of gross toxicity, adverse pharmacologic effects, or abnormal behavior.
- Body weight:
- All animals had gained weight in both dose groups by the end of the study.
- Gross pathology:
- No gross abnormalities were noted for any of the animals in either of the dose groups when necropsied at the conclusion of the 14-day observation period.
- Other findings:
- Not Applicable
Applicant's summary and conclusion
- Interpretation of results:
- other: no apparent toxicity at these dose levels
- Remarks:
- Criteria used for interpretation of results: not specified
- Conclusions:
- Under the conditions of this study, the acute inhalation LC50 of the test substance is greater than 5.08 mg/L in male and female rats.
- Executive summary:
Eurofins Product Safety Laboratory (EPSL) reported the findings of an independent test evaluating the acute inhalation toxicity of green nickel oxide as determined by the acute inhalation toxicity procedure in young male and female Sprague-Dawley albino rats (carried out according to OECD Test # 403 guidelines and using GLP standards). Green nickel oxide, Code: NI26-PTL and 98% pure, was aerosolized and concentrations were determined and maintained via gravimetric sampling from the breathing zone of the animals during each exposure. Prior to initiation of the full inhalation study, pre-test trials were conducted to establish generation procedures to achieve, to the extent possible, the targeted chamber concentration and desired particle size distribution [mass median aerodynamic diameter (MMAD) between 1.8 and 2.5 μm for the 0.18 mg/L dose level and between 1 and 4 um for the 5.0 mg/L dose level]. The estimated MMAD was 2.35 um (low dose) and 3.75 um (high dose). Five males and five females (ages 9-10 weeks old) were exposed nose-only to either 0.183 or 5.08 mg NiO/L air for 4 hours. All animals were observed for mortality during the exposure period. The animals were examined for signs of gross toxicity, and behavioral changes upon removal from the exposure chamber and at least once daily thereafter for up to 14 days. Observations included gross evaluation of skin and fur, eyes and mucous membranes, respiratory, circulatory, autonomic and central nervous systems, somatomotor activity and behavior pattern. Particular attention was directed to observation of tremors, convulsions, salivation, diarrhea, and coma. Body weights were measured prior to exposure, and then at days 7 and 14 of observation. All 10 animals in each dose group survived the observation period, gained weight, and appeared active and healthy. There were no signs of gross toxicity, adverse pharmacologic effects, or abnormal behavior. No gross abnormalities were noted for any of the animals in either of the dose groups when necropsied at the conclusion of the 14-day observation period. Under the conditions of this study, the acute inhalation LC50 of the test substance is greater than 5.08 mg/L in male and female rats. STUDY RATED BY AN INDEPENDENT REVIEWER.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)